Company / Capital Expenditures
HARROW, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$887.0K
FY2025
5-year range
$887.0K / $2.6M
FY2021-FY2025
Trend
-44.4%
vs FY2024
Sector context
#118 of 194
Health Care
What the data says
At $887,000, HARROW, INC.'s capital expenditures ranks #118 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from -$995,000 in FY2016 to $3M in FY2022.
Based on SEC 10-K filings.
$887,000 in FY2025 with a 5-year CAGR of +0.6%.
Declined from $1M to $887,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -30.1%
- 5-Year CAGR
- +0.6%
- 10-Year CAGR
- -
Sector benchmark
#118 of 194 in Health CareTop 61% of 194This company $887.0K Sector average $117.5M
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.6%, indicating consistent growth.
- In FY2025, capital expenditures decreased 44.4% year-over-year.
- Ranks #118 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $887.0K | -44.4% |
| FY2024 | $1.6M | +9.2% |
| FY2023 | $1.5M | -43.8% |
| FY2022 | $2.6M | +45.4% |
| FY2021 | $1.8M | +107.2% |
| FY2020 | $862.0K | -51.2% |
| FY2019 | $1.8M | +0.0% |
| FY2018 | $1.8M | +129.0% |
| FY2017 | $772.0K | +177.6% |
| FY2016 | -$995.0K | -671.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026